StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis 3. Neuroscience by Quarter

3. Neuroscience ($M)

QuarterlyAnnual

Novartis 3. Neuroscience: $1,975M in Q3 2026, up 22.7% from a year earlier. That is the highest of the 16 quarters on record here.

Latest, Q3 2026
1,975
Period ended Sep 30, 2026
Change on a year earlier
+22.7%
1,609 in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| Total neuroscience | 1 975 | 1 609 | 23 | 23”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K (Net sales by therapeutic area) & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEnded3. Neuroscience ($M)Year on yearSource
Q3 2026Sep 30, 20261,975+22.7%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20261,877+28.8%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20261,561+19.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20251,625+25.8%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20251,609+31.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20251,457+18.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20251,302+29.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20241,292+29.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20241,225+18.5%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20241,225+41.3%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20241,008+33.7%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023996+19.1%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,034–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023867–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023754–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022836–Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up 3. Neuroscience

Cite this data

StockData. (2026). Novartis 3. Neuroscience ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ta-neuroscience

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.